Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Moderna Inc (MRNA)

NASDAQ
Currency in USD
Disclaimer
105.64
-3.21(-2.95%)
Real-time Data

MRNA Price Commentary

let's rise moderna, don't fall and rise the price again
making profit. invest in novavax
it may go down below 350. don't buy @ this lavel
hopefully will go up
Correction as expected
Parabolic. Correction soon
Anyone know why its dropping rapidly, despite recommendations to buy?
i stand to coreect.. maybe in 15 days
moderna to be a 1000 dollar company soon .. probably in next 3 months..
probably...
i stand to correct.. maybe in 1 5 days
Hello, today the whole world is talking about the Moderna vaccine and the extension to other age groups
Amazing
I believe that we are at the beginning of a long journey: the quotation of Moderna today is related only to the Covid vaccine (Spikevax), as soon as the phases relating to the vaccine for CMV, HIV, CANCER and the others currently in progress are completed, it will not stop much easily . -Hello from the Moderna Italia forum-
guys what are your thoughts in the market....
sold some profits...amazing share wished i put more on them
this stock is scam like Tesla. Pfizer has more covid shots sold so why that one does not move that much
Pfizer stock price had always behaved like a flaccid penis
Pfizer has 5.5 billion outstanding shares whilst moderna has less than 500milliom hence price and fluctuations
Check the prices of the vaccines...then u will get the bug picture.
tgt 290
Thanks🙌
Sell side weak, support at 200, bullish. Same BNTX
As always it will drop soon and drop again before earnings date.
Bullish Bro
Vote bullish thanks you
Yes I think so too. MRNA have long time positive future.
I was thinking it could be time to buy Moderna. Next Quater could have another positive surprise and Covid isn't going away just like that.
My model predicts in 2022 a minimum price of 534 dollars per share. This is based on the forecasts of revenues of 2022, in a non favorable scenario. In a better scenario, Moderna could exceed 1000 dollars per share. The major asset of this company is the scalability and the ubiquitous use of digital technologies. Based on 2021 revenues forecast, each employee produces 4 millions in revenues. I could not find any other companies even close to this figure. I am glad people are wasting their money in crypto nonsense and tesla. Companies like moderna are estremely rare to find.
With Germany, Switzerland, UK and Canada against the IP waiver, the WTO will never get the unanimity, so even if Biden avail it, nothing will happen and the Pharma companies including Moderna will rightfully protect their intellectual property. The booster line in phase 2 is very promising and Moderna has a futuristic view into drugs development investing heavily into AI
The point is not the patent. The point is the manufacturing capability. It is too much to ask a policymaker to understand this argument.
With Germany, Switzerland, UK and Canada against the IP waiver, the WTO will never get the unanimity, so even if Biden avail it, nothing will happen and the Pharma companies including Moderna will rightfully protect their intellectual property. The booster line in phase 2 is very promising and Moderna has a futuristic view into drugs development investing heavily into AI ....
are the results out ?
What happened
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.